The impact of adjuvant EGFR-TKIs and 14-gene molecular assay on stage I non–small cell lung cancer with sensitive EGFR mutations-Reference-Cited by-同舟云学术

The impact of adjuvant EGFR-TKIs and 14-gene molecular assay on stage I non–small cell lung cancer with sensitive EGFR mutations

Published:2023-10 Issue: Volume:64 Page:102205
ISSN:2589-5370
Container-title:eClinicalMedicine
language:en
Short-container-title:eClinicalMedicine

Author:

Jiang Yu^ORCID,Lin Yuechun,Fu Wenhai,He Qihua,Liang Hengrui,Zhong Ran,Cheng Ran,Li Bingliang,Wen Yaokai,Wang Huiting,Li Jianfu,Li Caichen,Xiong Shan,Chen Songan,Xiang Jianxing,Mann Michael J.,He Jianxing,Liang Wenhua

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

General Medicine

Reference40 articles.

1. Cancer statistics, 2023;Siegel;CA Cancer J Clin,2023

2. The IASLC lung cancer staging project: external validation of the revision of the TNM stage groupings in the eighth edition of the TNM classification of lung cancer;Chansky;J Thorac Oncol,2017

3. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (Eighth) edition of the TNM classification for lung cancer;Goldstraw;J Thorac Oncol,2016

4. Postoperative adjuvant chemotherapy for stage I non-small cell lung cancer;Park;Eur J Cardiothorac Surg,2005

5. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group;Pignon;J Clin Oncol,2008

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlation Between the Number of Pathological Risk Factors and Postoperative Prognosis in Patients with Stage I Lung Adenocarcinoma;Annals of Surgical Oncology;2024-08-19

2. Habitat radiomics and deep learning fusion nomogram to predict EGFR mutation status in stage I non-small cell lung cancer: a multicenter study;Scientific Reports;2024-07-10

3. Adaptive medicine, a crucial component of optimized decision making: perspectives from lung cancer management;Translational Lung Cancer Research;2024-06

4. Beneficial implications of adjuvant chemotherapy for stage IB lung adenocarcinoma exhibiting elevated SUVmax in FDG-PET/CT: a retrospective study from a single center;Frontiers in Oncology;2024-03-11

5. Towards zero lung cancer;Chinese Medical Journal Pulmonary and Critical Care Medicine;2023-12